Medafor's FlexiTip™ Applicator Facilitates Wound Access During Surgery
MINNEAPOLIS, December 4, 2006 -- Medafor, Inc., announced today the introduction of the FlexiTip™ applicator for use with its Arista™ AH Absorbable Hemostat. Arista AH is the simple, safe and effective hemostatic powder recently approved by the FDA for most types of surgery including cardiac, orthopedic, spinal and general surgical applications. READ FULL STORY.

FDA Approves Medafor's Arista™AH Absorbable Surgical Hemostat for U.S. Operating Rooms
MINNEAPOLIS, October 3, 2006 -- Medafor, Inc., announced today that its Arista™ AH Absorbable Hemostat has received FDA approval to be marketed within the United States. Arista AH has been distributed internationally since 2002 and has compiled a remarkable record of surgical success around the world. In the U.S., this easy-to-use, efficacious and safe hemostat is indicated for most types of surgery including cardiac, orthopedic, spinal and general surgical applications. READ FULL STORY.

Medafor, Inc., Announces the Introduction of MPatcH® Vascular Closure Device to International Cardiology Markets
MINNEAPOLIS, August 15, 2006 -- Medafor, Inc., announced today that its MPatcH® vascular closure system will now be available to markets in Europe, Africa, the Middle East, Central and South America and Asia-Pacific. MPatcH® will be marketed through Medafor’s subsidiaries in Germany and France and its international distributor network. MPatcH® is distributed in the U.S. by Possis Medical, Inc. (NASDAQ:POSS). READ FULL STORY.

Possis Medical, Inc. Introduces New Solution For Endovascular Access Site Management
MINNEAPOLIS, MN.,--(BUSINESSWIRE)--May 11, 2006--Possis Medical, Inc. (NASDAQ:POSS) today announced the introduction of the SafeSeal™ Hemostasis Patch. This topical wound dressing decreases the time it takes to control bleeding from the puncture made into a blood vessel to perform an endovascular procedure. Designed to assist manual pressure and complement invasive vessel closure techniques, the SafeSeal Patch specifically targets the more than 7 million diagnostic and therapeutic procedures performed annually in the U.S. for coronary and peripheral applications. DOWNLOAD PDF.

2006

2003

2002

2001

2000

Chicago, Illinois
112th Annual Meeting and OTO Expo, American Academy of Otolaryngology
September 21-24, 2008

San Francisco, California
94th Annual Clinical Congress, American College of Surgeons
October 12-16, 2008

Medafor, Inc., was founded in 1999 to develop and market applications for its patented MPH® (Microporous Polysaccharide Hemospheres Technology). Statements presented on this page have not been evaluated by the U.S. FDA. See respective Instructions for Use for product applications and indications. Site content and images Copyright 2008 Medafor, Inc. All Rights Reserved. No part of this site may be copied, republished, excerpted or transferred to other media without the express written consent of Medafor, Inc. Arista™AH, MPH®, Medafor®, MPatcH®, FlexiTip™ are trademarks of Medafor, Inc. Other trademarks mentioned are the property of their respective companies. For information, contact Medafor at 1-763-571-6300.